Overview
Colon cancer is cancer that starts in the large intestine
(colon). There is no single cause of colon cancer. Nearly all colon cancers
begin as noncancerous (benign) polyps, which slowly develop into cancer. Many
cases of colon cancer have no symptoms. The following symptoms may indicate
colon cancer abdominal pain and tenderness in the lower abdomen, blood in the
stool, diarrhea, constipation, or other change in bowel habits, narrow stools
and weight loss with no known reason. Treatment includes surgery, radiation
therapy and chemotherapy.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1555338-colorectal-cancer-pipeline-review-h1-2017
Report
Highlights
The Pharmaceutical and Healthcare latest pipeline guide
Colorectal Cancer - Pipeline Review, H1 2017, provides comprehensive
information on the therapeutics under development for Colorectal Cancer
(Oncology), complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type. The
guide covers the descriptive pharmacological action of the therapeutics, its
complete research and development history and latest news and press releases.
The Colorectal Cancer (Oncology) pipeline guide also reviews
of key players involved in therapeutic development for Colorectal Cancer and
features dormant and discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules developed by
Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II,
Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 1, 25,
108, 137, 10, 173, 26 and 10 respectively. Similarly, the Universities
portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages
comprises 1, 18, 9, 28 and 5 molecules, respectively.
Major Scope of the report:
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Colorectal Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
Table of Contents
Table of Contents 2
Introduction 11
Colorectal Cancer - Overview 12
Colorectal Cancer - Therapeutics Development 13
Colorectal Cancer - Therapeutics Assessment 66
Colorectal Cancer - Companies Involved in Therapeutics Development 94
Colorectal Cancer - Drug Profiles 223
Colorectal Cancer - Dormant Projects 1708
Colorectal Cancer - Discontinued Products 1725
Colorectal Cancer - Product Development Milestones 1730
Appendix 1745
Introduction 11
Colorectal Cancer - Overview 12
Colorectal Cancer - Therapeutics Development 13
Colorectal Cancer - Therapeutics Assessment 66
Colorectal Cancer - Companies Involved in Therapeutics Development 94
Colorectal Cancer - Drug Profiles 223
Colorectal Cancer - Dormant Projects 1708
Colorectal Cancer - Discontinued Products 1725
Colorectal Cancer - Product Development Milestones 1730
Appendix 1745
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1555338-colorectal-cancer-pipeline-review-h1-2017
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner
Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
